Diagnosing endometriosis typically involves a combination of symptom evaluation, pelvic exams, imaging, and sometimes surgery. There is no single quick test that confirms it, which is a major reason the average time from first symptoms to diagnosis falls between 4 and 12 years, according to the World Health Organization. Understanding each step in the process can help you know what to expect and advocate for yourself along the way.
Why Diagnosis Takes So Long
Endometriosis symptoms overlap with many other conditions. Pelvic pain, painful periods, pain during sex, and digestive issues can also point to irritable bowel syndrome, urinary tract infections, ovarian cysts, pelvic inflammatory disease, or a condition called adenomyosis where tissue grows into the uterine wall itself. Clinicians need to work through these possibilities, and many people are told their pain is “normal” menstrual discomfort before endometriosis is seriously investigated.
A key clinical clue is when standard pain relievers and hormonal birth control don’t provide meaningful relief. Primary period pain usually responds well to those treatments. When it doesn’t, endometriosis moves higher on the list of suspects.
What Happens During a Pelvic Exam
A pelvic exam is usually the first hands-on step. During a bimanual exam, a clinician feels for physical abnormalities like nodules, tenderness, or masses. One finding stands out: nodularity along the ligaments behind the uterus. In studies of infertile women, this type of nodularity was found exclusively in those who had endometriosis and not in those without it, making it one of the most reliable physical signs. Tenderness in that same area, when paired with nodularity, also pointed strongly toward endometriosis.
That said, many people with endometriosis have a completely normal pelvic exam, especially in early stages. A normal exam does not rule the condition out.
Ultrasound as a First-Line Imaging Tool
Transvaginal ultrasound is the recommended first imaging test when endometriosis is suspected. A small probe is inserted into the vagina to create detailed images of the pelvic organs. It’s particularly good at spotting endometriomas, the fluid-filled cysts that form on the ovaries, and it can also detect deeper growths in some locations.
The strength of ultrasound is its specificity: when it does identify a lesion, it’s very likely to be real. Specificity ranges from 93% to 100% depending on the location being examined. The weakness is sensitivity, meaning it misses a significant number of lesions. For growths along the uterosacral ligaments, ultrasound picks up only about 53% of cases. For the rectovaginal septum (the tissue between the rectum and vagina), that number drops to around 49%. For the bladder, sensitivity is roughly 62%.
In practical terms, a positive ultrasound finding is highly trustworthy, but a “clear” ultrasound doesn’t mean you’re free of endometriosis. Superficial implants on the peritoneum (the lining of the abdominal cavity) are essentially invisible on ultrasound.
When MRI Is Used
MRI comes into play when deeper or more widespread disease is suspected, or when ultrasound results are inconclusive. It provides a wider anatomical view and is better at detecting growths in certain locations. For uterosacral ligament disease, MRI sensitivity ranges from 75% to 94%, compared to a more variable 25% to 83% for ultrasound. For the rectovaginal septum, MRI sensitivity runs 83% to 88% versus 67% to 73% for ultrasound.
MRI is especially useful before surgery. In one study, adding MRI to ultrasound improved the accuracy of surgical planning by nearly 19 percentage points, helping ensure the right specialists are in the operating room. Current UK and European guidelines recommend ultrasound first, with MRI reserved for suspected deep disease or cases where surgeons need a detailed map of what they’ll be working with.
Blood Tests and Their Limits
You may hear about a blood marker called CA-125, a protein that tends to be elevated in endometriosis and some other conditions. It can play a supporting role in initial screening, but it is not reliable enough on its own. When endometriosis involves ovarian cysts, CA-125 performs reasonably well, with diagnostic accuracy around 93%. Without ovarian cysts, accuracy drops to roughly 79%, and even then, the test works best when clinicians use lower-than-standard cutoff values (20 or 30 units per milliliter instead of the traditional 35).
CA-125 is also elevated in ovarian cancer, during menstruation, and in other inflammatory conditions, so an elevated result doesn’t point specifically to endometriosis. Most clinicians treat it as one piece of a larger puzzle rather than a standalone diagnostic tool.
Clinical Diagnosis Without Surgery
For years, surgical confirmation was considered the only way to diagnose endometriosis definitively. That standard has shifted. Updated European guidelines from 2022 no longer position laparoscopy as the automatic gold standard. Instead, they recommend surgery primarily when imaging is negative but symptoms persist, or when initial treatments haven’t worked.
This means many people now receive what’s called a clinical or presumptive diagnosis based on their symptoms, exam findings, and imaging results, and start treatment without ever having surgery. If hormonal therapy or other approaches relieve symptoms, that response itself supports the diagnosis. This shift is significant because it can shorten the diagnostic timeline and spare people an operation they may not need.
Laparoscopy for Definitive Confirmation
When a definitive answer is needed, laparoscopy remains the most certain path. It’s a minimally invasive surgery performed under general anesthesia. The surgeon makes a small incision near the navel and inserts a thin camera called a laparoscope to visually inspect the pelvic and abdominal cavity. They can see the location, size, and extent of endometriosis growths directly.
During the procedure, the surgeon typically takes a tissue sample (biopsy) from any suspicious areas. That tissue is examined under a microscope, and a pathologist confirms whether endometrial-type cells are present outside the uterus. This histologic confirmation is the only way to be 100% certain of a diagnosis. In many cases, the surgeon can also remove visible growths during the same operation, making laparoscopy both diagnostic and therapeutic.
How Endometriosis Is Staged
If surgery is performed, endometriosis is typically scored using a standardized system that assigns points based on the size of lesions on the peritoneum and ovaries, the extent of adhesions on the ovaries and fallopian tubes, and whether the space behind the uterus is partially or completely blocked. Only the largest growth in each area is counted. The total points place the disease into one of four stages:
- Stage I (minimal): 1 to 5 points
- Stage II (mild): 6 to 15 points
- Stage III (moderate): 16 to 40 points
- Stage IV (severe): more than 40 points
An important caveat: stage does not reliably predict pain levels. Someone with Stage I disease can experience debilitating symptoms, while someone with Stage IV may have relatively mild pain. The staging system is more useful for describing the physical extent of disease, particularly when assessing fertility, than for predicting how a person actually feels.
A Saliva Test on the Horizon
A saliva-based diagnostic test called Endotest is now available in France, where it is reimbursed and prescribed in 100 hospitals. It works by analyzing tiny RNA molecules in saliva and is designed for women aged 18 to 43 with chronic pelvic pain when imaging results are normal or inconclusive. Its clinical validation was published in the New England Journal of Medicine Evidence. The test is not yet available in the United States or most other countries, but it represents a meaningful step toward faster, non-invasive diagnosis for people stuck in the diagnostic gap between inconclusive imaging and surgery.